DAVID  ROWLEY  to  Mice, Inbred C3H
                            
                            
                                This is a "connection" page, showing publications  DAVID  ROWLEY  has written about  Mice, Inbred C3H.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0.118
         
        
        
     
 
    
        
        - 
            B lymphocytes secreting IgG linked to latent transforming growth factor-beta prevent primary cytolytic T lymphocyte responses. Int Immunol. 1998 Mar; 10(3):355-63.
            
            
                Score: 0.036
             
- 
            A first or dominant immunization. II. Induced immunoglobulin carries transforming growth factor beta and suppresses cytolytic T cell responses to unrelated alloantigens. J Exp Med. 1993 Sep 01; 178(3):841-52.
            
            
                Score: 0.026
             
- 
            A highly immunogenic tumor transfected with a murine transforming growth factor type beta 1 cDNA escapes immune surveillance. Proc Natl Acad Sci U S A. 1990 Feb; 87(4):1486-90.
            
            
                Score: 0.021
             
- 
            In vivo adenovirus-mediated suicide gene therapy of orthotopic bladder cancer. Mol Ther. 2000 Sep; 2(3):211-7.
            
            
                Score: 0.011
             
- 
            Adenovirus-mediated combination suicide and cytokine gene therapy for bladder cancer. Anticancer Res. 2000 May-Jun; 20(3A):1359-65.
            
            
                Score: 0.010
             
- 
            Adenovirus-mediated suicide gene therapy for experimental bladder cancer. Urology. 1997 Feb; 49(2):173-80.
            
            
                Score: 0.008
             
- 
            Stroma is critical for preventing or permitting immunological destruction of antigenic cancer cells. J Exp Med. 1992 Jan 01; 175(1):139-46.
            
            
                Score: 0.006